Friday, 25 October 2013

FDA OKs Second Agent to Aid Alzheimer's Dx

(MedPage Today) -- SILVER SPRING, Md. -- The FDA has approved flutemetamol (Vizamyl) for use with PET scans to evaluate beta-amyloid plaque burdens in the brains of living patients, making it the second such agent available in the U.S. via MedPageToday.com - medical news plus CME for physicians Read More Here..


Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/10/fda-oks-second-agent-to-aid-alzheimer-dx.html

No comments:

Post a Comment